1. "Hematologic Malignancies Service"
Formats
  1. Journal Article (349)
  2. Meeting Abstract (232)
  3. Review (11)
  4. Research Letter (5)
  5. Editorial (4)
  6. Book Section (2)
  7. Conference Paper (2)
  8. Correspondence (1)
  9. Guidelines (1)
Groups
  1. Hematologic Malignancies Service (607)
  2. Pediatrics, Department of (607)
  3. Center for Hematologic Malignancies (554)
  4. Pediatric Leukemia (455)
  5. GSK Faculty (220)
  6. Tow Center for Developmental Oncology (TCDO) (206)

More Groups

People
  1. Peter Steinherz (221)
  2. Neerav Shukla (159)
  3. Tanya Trippett (126)
  4. Alex Kentsis (103)
  5. Christopher Forlenza (49)
  6. Marc Ladanyi (44)

More People

Years
  1. 2025 (11)
  2. 2024 (27)
  3. 2023 (37)
  4. 2022 (34)
  5. 2021 (29)
  6. 2020 (29)

More Years

Publications
  1. Blood (125)
  2. Journal of Clinical Oncology (61)
  3. Pediatric Blood and Cancer (57)
  4. Cancer Research (22)
  5. Cancer (18)
  6. Journal of Pediatric Hematology/Oncology (16)

More Publications

Publishers
  1. American Society of Hematology (134)
  2. American Society of Clinical Oncology (69)
  3. Wiley Periodicals, Inc (57)
  4. American Association for Cancer Research (56)
  5. Nature Publishing Group (39)
  6. Elsevier Inc. (33)

More Publishers

Results (607)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • An experimental model for target modulation analysis in early clinical trials: Effects on Hsp90 client proteins in cells of patients treated with 17-AAG
    Meeting Abstract

    Narendran, A.; Gore, L.; Bagatell, R.; Whitlock, J.; Kersey, J.; Bolkan, J.; Katzenstein, H.; Hunger, S.; Amid, A.; Booth, K.; more...
    Pediatric Blood and Cancer (2007)

    Fulltext@MSK | Save
  • A novel therapy of clofarabine in combination with etoposide and cyclophosphamide shows activity in pediatric patients with refractory or relapsed acute leukemia
    Meeting Abstract

    Hijiya, N.; Gaynon, P.; Fernandez, M.; Rytting, M.; Chu, R.; Barry, E.; Thomson, B.; Cooper, T.; Kadota, R.; Chaleff, S.; more...
    Blood (2007)

    Fulltext@MSK | Save
  • Clinical outcomes of patients with recurrent/refractory Hodgkin disease receiving, cyclosporine, interferon-gamma, and interleukin-2 immunotherapy to induce autoreactivity after autologous stem cell transplantation with BEAM: A COG study
    Meeting Abstract

    Chen, A. R.; Hutchison, R.; Hess, A.; Gardner, S.; Trippett, T.; de Alarcon, P.; Hogan, S.; Mitchell, J.; Massey, V.; Constine, L. S.; more...
    Blood (2007)

    Fulltext@MSK | Save
  • TFE3 fusions activate MET signaling by transcriptional up-regulation, defining another class of tumors as candidates for therapeutic MET inhibition
    Journal Article

    Tsuda, M.; Davis, I. J.; Argani, P.; Shukla, N.; McGill, G. G.; Nagai, M.; Saito, T.; Lae, M.; Fisher, D. E.; Ladanyi, M.
    Cancer Research (2007)

    Fulltext@MSK | Save
  • Clofarabine induced durable complete remission in heavily pretreated adolescents with relapsed and refractory leukemia
    Journal Article

    Steinherz, P. G.; Meyers, P. A.; Steinherz, L. J.; Jeha, S.
    Journal of Pediatric Hematology/Oncology (2007)

    Fulltext@MSK | Save
  • The use of preoperative chemotherapy in Wilms' tumor with contained retroperitoneal rupture
    Journal Article

    Rutigliano, D. N.; Kayton, M. L.; Steinherz, P.; Wolden, S.; La Quaglia, M. P.
    Journal of Pediatric Surgery (2007)

    Fulltext@MSK | Save
  • A phase II trial of thalidomide and cyclophosphamide in patients with recurrent or refractory pediatric malignancies
    Journal Article

    Gilheeney, S. W.; Lyden, D. C.; Sgouros, S.; Antunes, N.; Gerald, W.; Kramer, K.; Lis, E.; Meyers, P.; Rosen, N.; Thaler, H. T.; more...
    Pediatric Blood and Cancer (2007)

    Fulltext@MSK | Save
  • Novel markers of subclinical disease for Ewing family tumors from gene expression profiling
    Journal Article

    Cheung, I. Y.; Feng, Y.; Danis, K.; Shukla, N.; Meyers, P.; Ladanyi, M.; Cheung, N. K. V.
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • Phase I pharmacokinetic and pharmacodynamic study of 17-N-allylamino-17- demethoxygeldanamycinin pediatric patients with recurrent or refractory solid tumors: A pediatric oncology experimental therapeutics investigators consortium study
    Journal Article

    Bagatell, R.; Gore, L.; Egorin, M. J.; Ho, R.; Heller, G.; Boucher, N.; Zuhowski, E. G.; Whitlock, J. A.; Hunger, S. P.; Narendran, A.; more...
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • Clofarabine in children with refractory/relapsed acute leukemia: Results of 2 phase II open-label studies
    Meeting Abstract

    Jeha, S.; Razzouk, B.; Gaynon, P.; Rytting, M.; Kadota, R.; Rheingold, S.; Luchtmanf-Jones, L.; Arceci, R.; Steinherz, P.
    Blood (2006)

    Fulltext@MSK | Save